Literature DB >> 10970060

Epidemiology of Parkinson's disease and akinetic syndromes.

C M Tanner1, D A Aston.   

Abstract

New reports of the incidence, prevalence and mortality of Parkinson's disease and parkinsonism are reviewed. Evidence for occupational and lifestyle risk factors and protective factors is updated. Recent genetic epidemiology studies of parkinsonism in twins and families, and studies that investigated imaging and physiologic markers of dopaminergic function in members without parkinsonism are presented.

Entities:  

Mesh：

Year:  2000        PMID： 10970060     DOI： 10.1097/00019052-200008000-00010

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN： 1350-7540            Impact factor:   5.710


  22 in total

Review 1.  Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease.

Authors:  Saranya Sundaram; Rachel L Hughes; Eric Peterson; Eva M Müller-Oehring; Helen M Brontë-Stewart; Kathleen L Poston; Afik Faerman; Chloe Bhowmick; Tilman Schulte
Journal:  Neurosci Biobehav Rev       Date:  2019-05-24       Impact factor: 8.989

Review 2.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

3.  Longitudinal white matter microstructural change in Parkinson's disease.

Authors:  Vincent Pozorski; Jennifer M Oh; Nagesh Adluru; Andrew P Merluzzi; Frances Theisen; Ozioma Okonkwo; Amy Barzgari; Stephanie Krislov; Jitka Sojkova; Barbara B Bendlin; Sterling C Johnson; Andrew L Alexander; Catherine L Gallagher
Journal:  Hum Brain Mapp       Date:  2018-06-27       Impact factor: 5.038

Review 4.  Epidemiology of Parkinson's disease.

Authors:  Guido Alves; Elin Bjelland Forsaa; Kenn Freddy Pedersen; Michaela Dreetz Gjerstad; Jan Petter Larsen
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

5.  Loudness Perception of Pure Tones in Parkinson's Disease.

Authors:  Defne Abur; Ashling A Lupiani; Ann E Hickox; Barbara G Shinn-Cunningham; Cara E Stepp
Journal:  J Speech Lang Hear Res       Date:  2018-06-19       Impact factor: 2.297

6.  Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: a pilot study.

Authors:  Rubén Martínez-Hernández; Sergio Montes; Jesus Higuera-Calleja; Petra Yescas; Marie-Catherine Boll; Araceli Diaz-Ruiz; Camilo Rios
Journal:  Neurochem Res       Date:  2011-06-26       Impact factor: 3.996

7.  Non-motor symptoms in Chinese Parkinson's disease patients with and without LRRK2 G2385R and R1628P variants.

Authors:  Da-Wei Li; Zhuqin Gu; Chaodong Wang; Jinghong Ma; Bei-Sha Tang; Sheng-Di Chen; Piu Chan
Journal:  J Neural Transm (Vienna)       Date:  2014-07-26       Impact factor: 3.575

8.  Mutant of leucine-rich repeat kinase 2 is not associated with non-motor symptoms in Chinese Parkinson's disease patients.

Authors:  Maolin Hao; Ning Pan; Qinghua Zhang; Xiaohong Wang
Journal:  Int J Clin Exp Med       Date:  2014-08-15

9.  Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits.

Authors:  Aysegul O Gezer; Joseph Kochmanski; Sarah E VanOeveren; Allyson Cole-Strauss; Christopher J Kemp; Joseph R Patterson; Kathryn M Miller; Nathan C Kuhn; Danielle E Herman; Alyssa McIntire; Jack W Lipton; Kelvin C Luk; Sheila M Fleming; Caryl E Sortwell; Alison I Bernstein
Journal:  Neurobiol Dis       Date:  2020-05-15       Impact factor: 5.996

10.  Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic clues.

Authors:  William Lin; Un Jung Kang
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.